Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/11/2025

Management of Elevated Triglyceride Levels

Classification and Risk Assessment

  • A triglyceride level of 359 mg/dL falls into the "high" category, which is associated with increased cardiovascular risk but below the threshold for acute pancreatitis concern 1
  • This level indicates atherogenic remnant lipoproteins and apolipoprotein CIII-enriched particles that contribute to cardiovascular disease risk 1
  • High triglycerides serve as a biomarker for visceral adiposity, insulin resistance, diabetes, and nonalcoholic hepatic steatosis 1

Initial Evaluation

  • Evaluate for secondary causes of hypertriglyceridemia, including uncontrolled diabetes, hypothyroidism, renal disease, excessive alcohol intake, medications, and liver disease 3, 4, 5, 6
  • Assess for other cardiovascular risk factors to determine overall risk profile 6
  • Rule out medications as potential causes of elevated triglycerides 2

Lifestyle Interventions

  • Implement intensive therapeutic lifestyle changes as first-line therapy, which can reduce triglyceride levels by up to 50% 2, 5
  • Target a 5-10% reduction in body weight, which can reduce triglycerides by approximately 20% 3, 4
  • Reduce carbohydrate intake, particularly added sugars and fructose 2
  • Increase unsaturated fat intake while restricting saturated and trans fats 2
  • Increase consumption of marine-based omega-3 products 2
  • Engage in regular aerobic activity (at least 150 minutes/week of moderate-intensity exercise) 3
  • Limit or completely avoid alcohol consumption 2, 3

Pharmacological Therapy

  • If triglyceride levels remain elevated after 3 months of lifestyle modifications, consider pharmacological intervention 4
  • For triglyceride levels between 200-499 mg/dL with increased cardiovascular risk, statins are first-line therapy if LDL-C is also elevated 7
  • Consider adding icosapent ethyl to statin therapy to further reduce cardiovascular risk 6
  • Fibrates are the most potent triglyceride-lowering agents (reducing levels by up to 50%) and should be considered if triglycerides remain elevated despite other interventions 7

Special Considerations

  • Statin plus fibrate combination therapy has not been shown to improve cardiovascular outcomes and is generally not recommended due to increased risk of myopathy 6
  • If diabetes is present, optimizing glycemic control can significantly improve triglyceride levels 3, 4
  • For women taking oral contraceptives who develop hypertriglyceridemia, consider lower estrogen-containing preparations or alternative contraception methods 2